David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Lennar Class B
LEN.B
$20.6B
| $1.14M | ﹤0.01% |
15,490
-3,287
| -18% | -$262K |
|
|
VRNT
3352
DELISTED
Verint Systems
VRNT
| $1.14M | ﹤0.01% |
25,416
-166,690
| -87% | -$7.25M |
|
|
GBT
3353
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.14M | ﹤0.01% |
+44,656
| New | +$1.31M |
|
|
ESTE
3354
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $1.14M | ﹤0.01% |
123,339
+2,618
| +2% | +$24.1K |
|
3355
Applied Optoelectronics
AAOI
$9.66B
| $1.13M | ﹤0.01% |
157,934
+12,902
| +9% | +$95.1K |
|
3356
PUT
Shutterstock
SSTK
$205M
| $1.13M | ﹤0.01% |
10,000
| – | – |
|
3357
AEON Biopharma
AEON
$12.5M
| $1.13M | ﹤0.01% |
1,613
+224
| +16% | +$156K |
|
3358
Leidos
LDOS
$17.2B
| $1.12M | ﹤0.01% |
+11,679
| New | +$1.16M |
|
3359
InnovAge Holding
INNV
$1.5B
| $1.12M | ﹤0.01% |
+169,807
| New | +$2.63M |
|
|
JBTM
3360
JBT Marel
JBTM
$6.22B
| $1.12M | ﹤0.01% |
7,981
-73,791
| -90% | -$10.6M |
|
3361
Alphatec Holdings
ATEC
$1.45B
| $1.12M | ﹤0.01% |
91,980
+72,649
| +376% | +$1.01M |
|
3362
Cognyte Software
CGNT
$627M
| $1.12M | ﹤0.01% |
+54,546
| New | +$1.39M |
|
3363
Commercial Vehicle Group
CVGI
$124M
| $1.12M | ﹤0.01% |
118,397
-100,049
| -46% | -$947K |
|
3364
PUT
CF Industries
CF
$19B
| $1.12M | ﹤0.01% |
20,000
| – | – |
|
|
CLLS
3365
Cellectis
CLLS
$344M
| $1.12M | ﹤0.01% |
88,522
-6,747
| -7% | -$93.5K |
|
3366
Arista Networks
ANET
$255B
| $1.11M | ﹤0.01% |
51,920
+32,032
| +161% | +$734K |
|
3367
PUT
Compass Minerals
CMP
$1.03B
| $1.11M | ﹤0.01% |
17,300
| – | – |
|
|
ICPT
3368
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.11M | ﹤0.01% |
+75,000
| New | +$1.2M |
|
|
MDP
3369
CALL
DELISTED
Meredith Corporation
MDP
| $1.11M | ﹤0.01% |
20,000
-90,300
| -82% | -$3.94M |
|
3370
Kanzhun
BZ
$8.42B
| $1.11M | ﹤0.01% |
30,893
-392,240
| -93% | -$13.9M |
|
3371
MicroCloud Hologram
HOLO
$41.9M
| $1.11M | ﹤0.01% |
+14
| New | +$1.1M |
|
3372
Ramaco Resources Class A
METC
$805M
| $1.11M | ﹤0.01% |
+93,230
| New | +$776K |
|
|
XHR
3373
Xenia Hotels & Resorts
XHR
$1.78B
| $1.1M | ﹤0.01% |
+62,295
| New | +$1.09M |
|
3374
Hyster-Yale Materials Handling
HY
$622M
| $1.1M | ﹤0.01% |
21,943
+13,254
| +153% | +$815K |
|
3375
Fox Factory Holding Corp
FOXF
$885M
| $1.1M | ﹤0.01% |
7,622
-6,091
| -44% | -$935K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.